This is a prospective observational study evaluating prehospital point-of-care high-sensitivity cardiac troponin I (hs-TnI) testing in patients with symptoms suggestive of acute coronary syndrome (ACS).
The aim of the study is to investigate the feasibility and diagnostic performance of measuring hs-TnI directly in the ambulance using the Abbott i-STAT Alinity point-of-care platform. In particular, the study investigates whether prehospital hs-TnI can help identify patients at very low risk of acute coronary syndrome and major adverse cardiac events.
Approximately 500 adult patients will be included by six study ambulances in the Central Denmark Region. A small venous blood sample is collected during the routine prehospital assessment and analysed for hs-TnI in the ambulance.
The hs-TnI result is collected for research purposes and does not influence the patient's assessment, treatment, triage or transport. Clinical care continues according to standard regional EMS procedures.
High-sensitivity cardiac troponin is an important biomarker used in hospitals in the assessment of patients with suspected acute coronary syndrome. However, evidence on high-sensitivity troponin testing in the prehospital setting remains limited. The ambulance environment differs from the hospital in several important ways, including the timing of blood sampling, practical sampling conditions and operational workflow.
Point-of-care technology now makes it possible to measure high-sensitivity cardiac troponin I from whole blood close to the patient. In this study, hs-TnI is measured using the Abbott i-STAT Alinity platform during the ambulance assessment.
The study will evaluate the diagnostic performance of prehospital hs-TnI for acute coronary syndrome, including its sensitivity, specificity, positive and negative predictive values and overall diagnostic accuracy. Feasibility of performing the test in routine ambulance care will also be evaluated.
Patient recruitment began on 1 July 2026. The study is conducted in six ambulances in the Central Denmark Region, with ambulance personnel trained in the study procedures and point-of-care testing.
Most diagnostic assessment for suspected acute coronary syndrome currently takes place after arrival at the hospital. Measuring hs-TnI already in the ambulance could provide diagnostic information earlier in the patient's pathway.
This study will provide evidence on whether high-sensitivity troponin can be measured reliably and practically in the prehospital setting and how well these measurements identify patients with and without acute coronary syndrome. The results may inform future research into how prehospital hs-TnI could support clinical decision-making before hospital arrival.